Pedro Gonzáles

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Raphael J. Landovitz, Deborah Donnell, Meredith E. Clement et al. · New England Journal of Medicine · 2021 · 853 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +16

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

Lawrence Corey, Peter B. Gilbert, Michal Juraska et al. · New England Journal of Medicine · 2021 · 539 citations · Full text

Life Sciences, Immunology, Infectious Diseases +8

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial

Kathleen Mulligan, David V. Glidden, Peter L. Anderson et al. · Clinical Infectious Diseases · 2015 · 150 citations · Full text

Public Health, Pharmacotherapy, Bone Metabolism +16

Acceptability and feasibility of HIV self-testing among men who have sex with men in Peru and Brazil

Jonathan E. Volk, Sheri A. Lippman, Beatriz Grinsztejn et al. · International Journal of STD & AIDS · 2015 · 89 citations · Full text

Public Health, Health Sciences, Infectious Disease Control +17

MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel

Ross Cranston, Javier R. Lama, Barbra A. Richardson et al. · Clinical Infectious Diseases · 2016 · 61 citations · Full text

Public Health, Pharmacotherapy, Sexuality Studies +15